This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2021
Title: Alex P Scopton: Innovator in Cancer Treatment
Introduction
Alex P Scopton is a notable inventor based in New York, NY (US), recognized for his contributions to the field of cancer treatment. With a total of 3 patents, he has made significant strides in developing innovative compounds and methods aimed at combating cancer.
Latest Patents
Among his latest patents is a groundbreaking invention related to kinase inhibitor compounds, compositions, and methods of treating cancer. This invention pertains to a compound characterized by a specific structure, which includes various components as described in the patent documentation. Additionally, he has developed KSR antagonists, which are designed to inhibit the Kinase Suppressor of Ras (KSR). This patent also encompasses pharmaceutical compositions that utilize KSR inhibitors and methods for treating cancer.
Career Highlights
Alex P Scopton is affiliated with the Icahn School of Medicine at Mount Sinai, where he continues to advance his research and innovations in cancer treatment. His work is pivotal in the ongoing battle against cancer, providing new avenues for therapeutic interventions.
Collaborations
He collaborates with esteemed colleagues such as Arvin C Dar and Ross L Cagan, contributing to a dynamic research environment focused on innovative cancer therapies.
Conclusion
Alex P Scopton's work exemplifies the critical role of inventors in the medical field, particularly in the development of novel cancer treatments. His patents and collaborations reflect a commitment to improving patient outcomes through innovative research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
